Skip to main content
MEMPHASYS LIMITED. logo

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,221 across all filing types
Latest filing 2009-08-13 Investor Presentation
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
NuSep Company Overview 7 pages ?Kb
Investor Presentation Classification · 95% confidence The document is a detailed company profile and overview of NuSep, including business operations, market segments, product descriptions, sales forecasts, and management team biographies. It contains no financial statements, regulatory certifications, voting results, or legal proceedings. It is not a formal annual or interim report, nor an earnings release or call transcript. The content is more akin to an investor presentation or company factsheet summarizing company strategy, market position, and financial outlook. Given the length (15,000 characters) and the detailed business and market information, the document fits best as an Investor Presentation (IP).
2009-08-13 English
Notice of Extraordinary General Meeting/Proxy Form 9 pages ?Kb
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of General Meeting for NuSep Ltd, detailing resolutions for shareholder approval regarding the issue of shares and an underwriting agreement with directors. It includes detailed explanations of the resolutions, voting exclusions, proxy instructions, and regulatory references such as the Corporations Act and ASX Listing Rules. The content focuses on capital raising and share issuance approvals requiring shareholder votes at a general meeting. This matches the definition of a Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. The document is not a full financial report, earnings release, or management report, but rather a detailed notice and explanatory statement for shareholder voting on capital changes and underwriting agreements.
2009-08-10 English
SPO Prospectus and Market Update 36 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from NuSep regarding a Share Purchase Offer (SPO) prospectus to raise $2 million. It includes extensive information about the SPO terms, timetable, company background, risk factors, underwriting agreements, and pro forma financial statements. The document is 15,000 characters long, indicating it is a full prospectus rather than a brief announcement. The content focuses on capital raising through a share issue, including pricing, underwriting, shareholder eligibility, and bonus shares. There is no indication that this is a full annual or interim financial report, earnings release, or management discussion. The primary purpose is to provide detailed information about the capital raising offer to shareholders and the market. Therefore, the document fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and capital structure changes.
2009-08-09 English
NuSep Lodges $2m SPO Prospectus 36 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus lodged with ASIC and ASX for a Share Purchase Offer (SPO) to raise $2 million by issuing new shares at a discount to existing shareholders. It includes a timetable, offer details, underwriting information, risk factors, and other relevant information typical of a capital raising document. The document is not an announcement of a report but the actual offering prospectus itself. This fits the category of Capital/Financing Update (CAP), as it relates to company fundraising and capital structure changes.
2009-08-05 English
NuSep Lodges Supplementary Prospectus 3 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is titled 'NuSep Lodges Supplementary Prospectus' and discusses lodging a supplementary prospectus with ASIC related to a Share Purchase Offer. It mentions withdrawing the original prospectus and issuing a new one. The content focuses on the prospectus and underwriting changes, which are related to capital raising activities. There is no financial report or earnings data presented, only an announcement about the supplementary prospectus filing. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is 4560 characters, which is sufficient to be more than a brief announcement but it is clearly about a financing prospectus update, not a full report or regulatory filing. Therefore, the best classification is CAP with high confidence.
2009-07-28 English
NuSep Confirms $1m Underwriting of SPO 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that NuSep has secured a $1 million underwriting commitment for a Share Purchase Offer (SPO). It discusses the underwriting commitments by directors and shareholders, the upcoming SPO prospectus, and an Extraordinary General Meeting to approve the SPO and underwriting agreement. There are no financial statements, detailed financial analysis, or regulatory certifications present. The document is focused on capital raising activity and underwriting commitments, which aligns with a Capital/Financing Update. The document length is 3663 characters, which is relatively short and typical for an announcement rather than a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2009-07-28 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.